Jonathan H Engbers, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2121 Hegg Dr, Rock Valley, IA 51247 Phone: 712-476-8150 Fax: 712-476-8190 |
Sarah Connors Beucher, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1202 21st Ave, Rock Valley, IA 51247 Phone: 712-476-8100 |
Bradley Dean Kamstra, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2121 Hegg Dr, Rock Valley, IA 51247 Phone: 712-476-8100 Fax: 712-476-8190 |
Paul W Dejong, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1202 21st Ave, Rock Valley, IA 51247 Phone: 712-476-8100 Fax: 712-476-8190 |
News Archive
Plenty of hospitals and medical providers claim they do a great job at caring for patients and protecting their safety during care. But very few actually publish the cold, hard numbers that could prove those claims. And even fewer do it like the University of Michigan Health System has: on a website open to anyone, with dozens of charts and graphs showing actual performance and comparisons to national averages and benchmarks.
A team of researchers working at the MR-Center of the University Children's Hospital in Zürich has completed a pilot study using transcranial MR-guided focused ultrasound to treat 10 patients with neuropathic pain.
Diabetes mellitus is associated with various health problems including decline in skeletal muscle mass. A research group led by Professor Wataru Ogawa at the Kobe University Graduate School of Medicine revealed that elevation of blood sugar levels leads to muscle atrophy and that two proteins, WWP1 and KLF15, play key roles in this phenomenon.
iCo Therapeutics Inc. (the "Company") is pleased to announce that further to its press release issued October 20, 2009 announcing a $4,000,000 brokered private placement (the "Offering") co-led by Loewen, Ondaatje, McCutcheon Limited and Versant Partners Inc. (collectively, the "Agents"), the Company has completed the first tranche of the Offering through the issuance of 6,000,000 common shares of Company (the "Shares"). The Shares were issued at a price of $0.48 per share for gross proceeds of $2,880,000.
› Verified 3 days ago